Zhang et al. report a phase 2 trial evaluating neoadjuvant fuzuloparib plus abiraterone in treatment-naive men with high-risk localized prostate cancer. The combined pCR/MRD rate is 46%, with a 53%...
This video discussed on top software solutions that will not only b...
ALT pc GIF
ALT Top 20 Tricks to Gain your PC Performance on Windows-10?